Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program.

Xie JX, Gunzburger EC, Kaun L, Plomondon ME, Barón AE, Waldo SW, Virani SS, Maddox TM, Mavromatis K.

Circ Cardiovasc Qual Outcomes. 2019 Nov;12(11):e005455. doi: 10.1161/CIRCOUTCOMES.118.005455. Epub 2019 Oct 31.

PMID:
31665896
2.

Predicting Hospital Readmissions from Home Healthcare in Medicare Beneficiaries.

Jones CD, Falvey J, Hess E, Levy CR, Nuccio E, Barón AE, Masoudi FA, Stevens-Lapsley J.

J Am Geriatr Soc. 2019 Dec;67(12):2505-2510. doi: 10.1111/jgs.16153. Epub 2019 Aug 29.

PMID:
31463941
3.

Patient Reminders and Longitudinal Adherence to Lung Cancer Screening in an Academic Setting.

Hirsch EA, New ML, Brown SP, Barón AE, Malkoski SP.

Ann Am Thorac Soc. 2019 Oct;16(10):1329-1332. doi: 10.1513/AnnalsATS.201902-152RL. No abstract available.

PMID:
31339348
4.

Association of Coronary Anatomical Complexity With Clinical Outcomes After Percutaneous or Surgical Revascularization in the Veterans Affairs Clinical Assessment Reporting and Tracking Program.

Valle JA, Glorioso TJ, Bricker R, Barón AE, Armstrong EJ, Bhatt DL, Rao SV, Plomondon ME, Serruys PW, Keppetein AP, Sabik JF, Dressler O, Stone GW, Waldo SW.

JAMA Cardiol. 2019 Jun 26. doi: 10.1001/jamacardio.2019.1923. [Epub ahead of print]

PMID:
31241721
5.

Advancing Symptom Alleviation with Palliative Treatment (ADAPT) trial to improve quality of life: a study protocol for a randomized clinical trial.

Graney BA, Au DH, Barón AE, Cheng A, Combs SA, Glorioso TJ, Paden G, Parsons EC, Rabin BA, Ritzwoller DP, Stonecipher JJ, Turvey C, Welsh CH, Bekelman DB.

Trials. 2019 Jun 13;20(1):355. doi: 10.1186/s13063-019-3417-1.

6.

Real-world effectiveness of infection prevention interventions for reducing procedure-related cardiac device infections: Insights from the veterans affairs clinical assessment reporting and tracking program.

Asundi A, Stanislawski M, Mehta P, Baron AE, Mull HJ, Ho PM, Zimetbaum PJ, Gupta K, Branch-Elliman W.

Infect Control Hosp Epidemiol. 2019 Aug;40(8):855-862. doi: 10.1017/ice.2019.127. Epub 2019 Jun 4.

PMID:
31159895
7.

Gluten Intake and Risk of Celiac Disease: Long-Term Follow-up of an At-Risk Birth Cohort.

Mårild K, Dong F, Lund-Blix NA, Seifert J, Barón AE, Waugh KC, Taki I, Størdal K, Tapia G, Stene LC, Johnson RK, Liu E, Rewers MJ, Norris JM.

Am J Gastroenterol. 2019 Aug;114(8):1307-1314. doi: 10.14309/ajg.0000000000000255.

PMID:
31082869
8.

Transitional Care Outcomes in Veterans Receiving Post-Acute Care in a Skilled Nursing Facility.

Burke RE, Canamucio A, Glorioso TJ, Barón AE, Ryskina KL.

J Am Geriatr Soc. 2019 Sep;67(9):1820-1826. doi: 10.1111/jgs.15971. Epub 2019 May 10.

PMID:
31074844
9.

Gluten Intake and Risk of Islet Autoimmunity and Progression to Type 1 Diabetes in Children at Increased Risk of the Disease: The Diabetes Autoimmunity Study in the Young (DAISY).

Lund-Blix NA, Dong F, Mårild K, Seifert J, Barón AE, Waugh KC, Joner G, Størdal K, Tapia G, Stene LC, Johnson RK, Rewers MJ, Norris JM.

Diabetes Care. 2019 May;42(5):789-796. doi: 10.2337/dc18-2315. Epub 2019 Feb 22.

PMID:
30796108
10.

Detection of oligoprogressive disease in oncogene-addicted non-small cell lung cancer using PET/CT versus CT in patients receiving a tyrosine kinase inhibitor.

Ng TL, Morgan RL, Patil T, Barón AE, Smith DE, Ross Camidge D.

Lung Cancer. 2018 Dec;126:112-118. doi: 10.1016/j.lungcan.2018.10.023. Epub 2018 Oct 23.

PMID:
30527174
11.

Predictors and Outcomes of Staged Versus One-Time Multivessel Revascularization in Multivessel Coronary Artery Disease: Insights From the VA CART Program.

Hu PT, Jones WS, Glorioso TJ, Barón AE, Grunwald GK, Waldo SW, Maddox TM, Vidovich M, Banerjee S, Rao SV.

JACC Cardiovasc Interv. 2018 Nov 26;11(22):2265-2273. doi: 10.1016/j.jcin.2018.07.055.

12.

Prolonged antimicrobial prophylaxis following cardiac device procedures increases preventable harm: insights from the VA CART program.

Asundi A, Stanislawski M, Mehta P, Barón AE, Gold H, Mull H, Ho PM, Gupta K, Branch-Elliman W.

Infect Control Hosp Epidemiol. 2018 Sep;39(9):1030-1036. doi: 10.1017/ice.2018.170.

PMID:
30226128
13.

Trajectories of Nevus Development From Age 3 to 16 Years in the Colorado Kids Sun Care Program Cohort.

Asdigian NL, Barón AE, Morelli JG, Mokrohisky ST, Aalborg J, Dellavalle RP, Daley MF, Berwick M, Muller KE, Box NF, Crane LA.

JAMA Dermatol. 2018 Nov 1;154(11):1272-1280. doi: 10.1001/jamadermatol.2018.3027.

14.

Temporal trends in the management and clinical outcomes of lower extremity arterial thromboembolism within a national Veteran population.

Prouse AF, Langner P, Plomondon ME, Ho PM, Valle JA, Barón AE, Armstrong EJ, Waldo SW.

Vasc Med. 2019 Feb;24(1):41-49. doi: 10.1177/1358863X18793210. Epub 2018 Aug 14.

PMID:
30105938
15.

Requirement for MUC5AC in KRAS-dependent lung carcinogenesis.

Bauer AK, Umer M, Richardson VL, Cumpian AM, Harder AQ, Khosravi N, Azzegagh Z, Hara NM, Ehre C, Mohebnasab M, Caetano MS, Merrick DT, van Bokhoven A, Wistuba II, Kadara H, Dickey BF, Velmurugan K, Mann PR, Lu X, Barón AE, Evans CM, Moghaddam SJ.

JCI Insight. 2018 Aug 9;3(15). pii: 120941. doi: 10.1172/jci.insight.120941. eCollection 2018 Aug 9.

16.

Altered Cell-Cycle Control, Inflammation, and Adhesion in High-Risk Persistent Bronchial Dysplasia.

Merrick DT, Edwards MG, Franklin WA, Sugita M, Keith RL, Miller YE, Friedman MB, Dwyer-Nield LD, Tennis MA, O'Keefe MC, Donald EJ, Malloy JM, van Bokhoven A, Wilson S, Koch PJ, O'Shea C, Coldren C, Orlicky DJ, Lu X, Baron AE, Hickey G, Kennedy TC, Powell R, Heasley L, Bunn PA, Geraci M, Nemenoff RA.

Cancer Res. 2018 Sep 1;78(17):4971-4983. doi: 10.1158/0008-5472.CAN-17-3822. Epub 2018 Jul 11.

17.

The Associations Between Falls, Fall Injuries, and Labor Market Outcomes Among U.S. Workers 65 Years and Older.

Scott KA, Fisher GG, Barón AE, Tompa E, Stallones L, DiGuiseppi C.

J Occup Environ Med. 2018 Oct;60(10):943-953. doi: 10.1097/JOM.0000000000001379.

PMID:
29905647
18.

The implications of cocaine use and associated behaviors on adverse cardiovascular outcomes among veterans: Insights from the VA Clinical Assessment, Reporting, and Tracking (CART) Program.

Gunja A, Stanislawski MA, Barón AE, Maddox TM, Bradley SM, Vidovich MI.

Clin Cardiol. 2018 Jun;41(6):809-816. doi: 10.1002/clc.22961. Epub 2018 Jun 9.

19.

Clinical and laboratory factors contributing to uninterpretable beryllium lymphocyte proliferation tests (BeLPT).

Smith DE, Golden AP, Stange AW, Barker E, Mroz M, Barón AE, Ghosh D, Maier L, Cragle D, Newman LS.

Am J Ind Med. 2018 Jul;61(7):592-604. doi: 10.1002/ajim.22842. Epub 2018 Mar 24.

PMID:
29574954
20.

Predicting Potential Adverse Events During a Skilled Nursing Facility Stay: A Skilled Nursing Facility Prognosis Score.

Burke RE, Hess E, Barón AE, Levy C, Donzé JD.

J Am Geriatr Soc. 2018 May;66(5):930-936. doi: 10.1111/jgs.15324. Epub 2018 Mar 2.

21.

Coronary artery disease severity modifies associations between glycemic control and both mortality and myocardial infarction.

Raghavan S, Liu WG, Michael Ho P, Plomondon ME, Barón AE, Caplan L, Joynt Maddox KE, Magid D, Saxon DR, Voils CI, Bradley SM, Maddox TM.

J Diabetes Complications. 2018 May;32(5):480-487. doi: 10.1016/j.jdiacomp.2018.01.010. Epub 2018 Jan 31.

22.

H2 Receptor Antagonist Use and Mortality in Pulmonary Hypertension: Insight from the VA-CART Program.

Leary PJ, Hess E, Barón AE, Branch KR, Choudhary G, Hough CL, Maron BA, Ralph DD, Ryan JJ, Tedford RJ, Weiss NS, Zamanian RT, Lahm T.

Am J Respir Crit Care Med. 2018 Jun 15;197(12):1638-1641. doi: 10.1164/rccm.201801-0048LE. No abstract available.

23.

Exhaustion of Airway Basal Progenitor Cells in Early and Established Chronic Obstructive Pulmonary Disease.

Ghosh M, Miller YE, Nakachi I, Kwon JB, Barón AE, Brantley AE, Merrick DT, Franklin WA, Keith RL, Vandivier RW.

Am J Respir Crit Care Med. 2018 Apr 1;197(7):885-896. doi: 10.1164/rccm.201704-0667OC.

24.

Same-level fall injuries in US workplaces by age group, gender, and industry.

Scott KA, Fisher GG, Barón AE, Tompa E, Stallones L, DiGuiseppi C.

Am J Ind Med. 2018 Feb;61(2):111-119. doi: 10.1002/ajim.22796. Epub 2017 Nov 30.

PMID:
29193187
25.

Sex-based differences in veterans with pulmonary hypertension: Results from the veterans affairs-clinical assessment reporting and tracking database.

Ventetuolo CE, Hess E, Austin ED, Barón AE, Klinger JR, Lahm T, Maddox TM, Plomondon ME, Thompson L, Zamanian RT, Choudhary G, Maron BA.

PLoS One. 2017 Nov 9;12(11):e0187734. doi: 10.1371/journal.pone.0187734. eCollection 2017.

26.

Validation of an electronic tool for flagging surgical site infections based on clinical practice patterns for triaging surveillance: Operational successes and barriers.

Pindyck T, Gupta K, Strymish J, Itani KM, Carter ME, Suo Y, Bessesen MT, Topkoff J, Steele AS, Barón AE, Gundlapalli AV, Branch-Elliman W.

Am J Infect Control. 2018 Feb;46(2):186-190. doi: 10.1016/j.ajic.2017.08.026. Epub 2017 Oct 12.

PMID:
29031434
27.

Thermodilution vs Estimated Fick Cardiac Output Measurement in Clinical Practice: An Analysis of Mortality From the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program and Vanderbilt University.

Opotowsky AR, Hess E, Maron BA, Brittain EL, Barón AE, Maddox TM, Alshawabkeh LI, Wertheim BM, Xu M, Assad TR, Rich JD, Choudhary G, Tedford RJ.

JAMA Cardiol. 2017 Oct 1;2(10):1090-1099. doi: 10.1001/jamacardio.2017.2945.

28.

Baseline and On-Treatment Characteristics of Serum Tumor Markers in Stage IV Oncogene-Addicted Adenocarcinoma of the Lung.

Noonan SA, Patil T, Gao D, King GG, Thibault JR, Lu X, Bunn PA, Doebele RC, Purcell WT, Barón AE, Camidge DR.

J Thorac Oncol. 2018 Jan;13(1):134-138. doi: 10.1016/j.jtho.2017.08.005. Epub 2017 Aug 24.

29.

Coronary atherectomy is associated with improved procedural and clinical outcomes among patients with calcified coronary lesions: Insights from the VA CART program.

Armstrong EJ, Stanislawski MA, Kokkinidis DG, Plomondon ME, Barón AE, Giri J, Shunk KA, Banerjee S, Maddox TM, Waldo SW.

Catheter Cardiovasc Interv. 2018 May 1;91(6):1009-1017. doi: 10.1002/ccd.27213. Epub 2017 Aug 2.

PMID:
28766833
30.

Clinical Utility of Chromosomal Aneusomy in Individuals at High Risk of Lung Cancer.

Barón AE, Kako S, Feser WJ, Malinowski H, Merrick D, Garg K, Malkoski S, Pretzel S, Siegfried JM, Franklin WA, Miller Y, Wolf HJ, Varella-Garcia M.

J Thorac Oncol. 2017 Oct;12(10):1512-1523. doi: 10.1016/j.jtho.2017.06.008. Epub 2017 Jun 19.

31.

Late-onset islet autoimmunity in childhood: the Diabetes Autoimmunity Study in the Young (DAISY).

Frohnert BI, Ide L, Dong F, Barón AE, Steck AK, Norris JM, Rewers MJ.

Diabetologia. 2017 Jun;60(6):998-1006. doi: 10.1007/s00125-017-4256-9. Epub 2017 Mar 17.

32.

High Incidence of Celiac Disease in a Long-term Study of Adolescents With Susceptibility Genotypes.

Liu E, Dong F, Barón AE, Taki I, Norris JM, Frohnert BI, Hoffenberg EJ, Rewers M.

Gastroenterology. 2017 May;152(6):1329-1336.e1. doi: 10.1053/j.gastro.2017.02.002. Epub 2017 Feb 7.

33.

Effect of Chronic Kidney Disease on Mortality in Patients Who Underwent Lower Extremity Peripheral Vascular Intervention.

Xie JX, Glorioso TJ, Dattilo PB, Aggarwal V, Ho PM, Barón AE, Donaldson D, Armstrong EJ, Klein A, Giri J, Tsai TT.

Am J Cardiol. 2017 Feb 15;119(4):669-674. doi: 10.1016/j.amjcard.2016.10.053. Epub 2016 Nov 16.

PMID:
28027725
34.

Telemedicine Specialty Support Promotes Hepatitis C Treatment by Primary Care Providers in the Department of Veterans Affairs.

Beste LA, Glorioso TJ, Ho PM, Au DH, Kirsh SR, Todd-Stenberg J, Chang MF, Dominitz JA, Barón AE, Ross D.

Am J Med. 2017 Apr;130(4):432-438.e3. doi: 10.1016/j.amjmed.2016.11.019. Epub 2016 Dec 18.

PMID:
27998682
35.

Facility-Level Percutaneous Coronary Intervention Readmission Rates Are Not Associated With Facility-Level Mortality: Insights From the VA Clinical Assessment, Reporting, and Tracking (CART) Program.

Hegeman TW, Glorioso TJ, Hess E, Barón AE, Ho PM, Maddox TM, Bradley SM, Burke RE.

J Am Heart Assoc. 2016 Sep 14;5(9). pii: e003503. doi: 10.1161/JAHA.116.003503.

36.

Cardiac Electrophysiology Laboratories: A Potential Target for Antimicrobial Stewardship and Quality Improvement?

Branch-Elliman W, Stanislawski M, Strymish J, Barón AE, Gupta K, Varosy PD, Gold HS, Ho PM.

Infect Control Hosp Epidemiol. 2016 Sep;37(9):1005-11. doi: 10.1017/ice.2016.116. Epub 2016 Jun 20.

PMID:
27322021
37.

Identifying the Appropriate FISH Criteria for Defining MET Copy Number-Driven Lung Adenocarcinoma through Oncogene Overlap Analysis.

Noonan SA, Berry L, Lu X, Gao D, Barón AE, Chesnut P, Sheren J, Aisner DL, Merrick D, Doebele RC, Varella-Garcia M, Camidge DR.

J Thorac Oncol. 2016 Aug;11(8):1293-1304. doi: 10.1016/j.jtho.2016.04.033. Epub 2016 Jun 1.

38.

Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.

Barnes GD, Stanislawski MA, Liu W, Barón AE, Armstrong EJ, Ho PM, Klein A, Maddox TM, Nallamothu BK, Rumsfeld JS, Tsai TT, Bradley SM.

Circ Cardiovasc Qual Outcomes. 2016 Jul;9(4):406-13. doi: 10.1161/CIRCOUTCOMES.115.002043. Epub 2016 May 31.

39.

Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.

Maron BA, Hess E, Maddox TM, Opotowsky AR, Tedford RJ, Lahm T, Joynt KE, Kass DJ, Stephens T, Stanislawski MA, Swenson ER, Goldstein RH, Leopold JA, Zamanian RT, Elwing JM, Plomondon ME, Grunwald GK, Barón AE, Rumsfeld JS, Choudhary G.

Circulation. 2016 Mar 29;133(13):1240-8. doi: 10.1161/CIRCULATIONAHA.115.020207. Epub 2016 Feb 12.

40.

A Brief Report of the Status of Central Nervous System Metastasis Enrollment Criteria for Advanced Non-Small Cell Lung Cancer Clinical Trials: A Review of the ClinicalTrials.gov Trial Registry.

McCoach CE, Berge EM, Lu X, Barón AE, Camidge DR.

J Thorac Oncol. 2016 Mar;11(3):407-13. doi: 10.1016/j.jtho.2015.10.024. Epub 2015 Dec 25.

41.

Persistence of Bronchial Dysplasia Is Associated with Development of Invasive Squamous Cell Carcinoma.

Merrick DT, Gao D, Miller YE, Keith RL, Baron AE, Feser W, Kennedy TC, Blatchford PJ, Braudrick S, Hirsch FR, Heasley L, Bunn PA Jr, Franklin WA.

Cancer Prev Res (Phila). 2016 Jan;9(1):96-104. doi: 10.1158/1940-6207.CAPR-15-0305. Epub 2015 Nov 5.

42.

Independent validation test of the vote-counting strategy used to rank biomarkers from published studies.

Rikke BA, Wynes MW, Rozeboom LM, Barón AE, Hirsch FR.

Biomark Med. 2015;9(8):751-61. doi: 10.2217/BMM.15.39. Epub 2015 Jul 30.

43.

Stress Testing After Percutaneous Coronary Intervention in the Veterans Affairs HealthCare System: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.

Bradley SM, Hess E, Winchester DE, Sussman JB, Aggarwal V, Maddox TM, Barón AE, Rumsfeld JS, Ho PM.

Circ Cardiovasc Qual Outcomes. 2015 Sep;8(5):486-92. doi: 10.1161/CIRCOUTCOMES.114.001561. Epub 2015 Jul 21.

PMID:
26198400
44.

The impact of adjuvant radiation therapy for high-grade gliomas by histology in the United States population.

Rusthoven CG, Carlson JA, Waxweiler TV, Dally MJ, Barón AE, Yeh N, Gaspar LE, Liu AK, Ney DE, Damek DM, Lillehei KO, Kavanagh BD.

Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):894-902. doi: 10.1016/j.ijrobp.2014.07.046. Epub 2014 Oct 18.

PMID:
25585784
45.

Interactions between ultraviolet light and MC1R and OCA2 variants are determinants of childhood nevus and freckle phenotypes.

Barón AE, Asdigian NL, Gonzalez V, Aalborg J, Terzian T, Stiegmann RA, Torchia EC, Berwick M, Dellavalle RP, Morelli JG, Mokrohisky ST, Crane LA, Box NF.

Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2829-39. doi: 10.1158/1055-9965.EPI-14-0633.

46.

Survival benefit of repeat liver transplantation in the United States: a serial MELD analysis by hepatitis C status and donor risk index.

Biggins SW, Gralla J, Dodge JL, Bambha KM, Tong S, Barón AE, Inadomi J, Terrault N, Rosen HR.

Am J Transplant. 2014 Nov;14(11):2588-94. doi: 10.1111/ajt.12867. Epub 2014 Sep 19.

47.

Adherence to dabigatran therapy and longitudinal patient outcomes: insights from the veterans health administration.

Shore S, Carey EP, Turakhia MP, Jackevicius CA, Cunningham F, Pilote L, Bradley SM, Maddox TM, Grunwald GK, Barón AE, Rumsfeld JS, Varosy PD, Schneider PM, Marzec LN, Ho PM.

Am Heart J. 2014 Jun;167(6):810-7. doi: 10.1016/j.ahj.2014.03.023. Epub 2014 Apr 5.

48.

Deaths and cardiovascular events in men receiving testosterone--reply.

Ho PM, Barón AE, Wierman ME.

JAMA. 2014 Mar 5;311(9):964-5. doi: 10.1001/jama.2014.401. No abstract available.

PMID:
24595788
49.

GLIMMPSE: Online Power Computation for Linear Models with and without a Baseline Covariate.

Kreidler SM, Muller KE, Grunwald GK, Ringham BM, Coker-Dukowitz ZT, Sakhadeo UR, Barón AE, Glueck DH.

J Stat Softw. 2013 Sep;54(10). pii: i10.

50.

Drug-induced reduction in estimated glomerular filtration rate in patients with ALK-positive non-small cell lung cancer treated with the ALK inhibitor crizotinib.

Brosnan EM, Weickhardt AJ, Lu X, Maxon DA, Barón AE, Chonchol M, Camidge DR.

Cancer. 2014 Mar 1;120(5):664-74. doi: 10.1002/cncr.28478. Epub 2013 Nov 20.

Supplemental Content

Loading ...
Support Center